HuGE Literature Finder
Records 1-30
|
A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics.
Blood cancer journal 2020 Apr 10 (4): 43. Sánchez Ricardo, Ribera Jordi, Morgades Mireia, Ayala Rosa, Onecha Esther, Ruiz-Heredia Yanira, Juárez-Rufián Alexandra, de Nicolás Rodrigo, Sánchez-Pina José, Vives Susana, Zamora Lurdes, Mercadal Santiago, Coll Rosa, Cervera Marta, García Olga, Ribera Josep-Maria, Martínez-López Joaqu |
|
The Prognostic Significance of TET2 Single Nucleotide Polymorphism in Egyptian Chronic Myeloid Leukemia.
Mediterranean journal of hematology and infectious diseases 2020 12 (1): e2020004. Hamed Nahla A, Elhalawani Nabil A, Kassem Heba S, Ayad Mona W, Dammag Enas |
|
Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).
Haematologica 2019 Dec . Jaramillo Sonia, Agathangelidis Andreas, Schneider Christof, Bahlo Jasmin, Robrecht Sandra, Tausch Eugen, Bloehdorn Johannes, Hoechstetter Manuela, Fischer Kirsten, Eichhorst Barbara, Goede Valentin, Hallek Michael, Döhner Hartmut, Rosenquist Richard, Ghia Paolo, Stamatopoulos Kostas, Stilgenbauer Steph |
|
Lack of association between functional polymorphism of DNA repair genes (XRCC1, XPD) and clinical response in Indian chronic myeloid leukemia patients.
Molecular biology reports 2019 Jul . Dhangar Somprakash, Shanbhag Vinay, Shanmukhaiah Chandrakala, Vundinti Babu R |
|
Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response.
Molecular genetics & genomic medicine 2019 May e717. Rostami Golale, Assad Dlnya, Ghadyani Fatemeh, Hamid Mohammad, Karami Amirhossien, Jalaeikhoo Hasan, Kalahroodi Ramezan A |
|
Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid Leukemia.
Clinical lymphoma, myeloma & leukemia 2019 Feb . Yoo Hea-Lyun, Kim Soo-Hyun, Choi Soo-Young, Lee Sung-Eun, Kim Dong-Wo |
|
Single nucleotide polymorphism in PTEN-Long gene: A risk factor in chronic myeloid leukemia.
Gene 2019 Feb 694 71-75. Ferri C, Weich N, Gutiérrez L, De Brasi C, Bengió M R, Zapata P, Fundia A, Larripa |
|
Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
Haematologica 2019 Jan . Zaliova Marketa, Stuchly Jan, Winkowska Lucie, Musilova Alena, Fiser Karel, Slamova Martina, Starkova Julia, Vaskova Martina, Hrusak Ondrej, Sramkova Lucie, Stary Jan, Zuna Jan, Trka J |
|
Evidence that 6q25.1 variant rs6931104 confers susceptibility to chronic myeloid leukemia through RMND1 regulation.
PloS one 2019 14 (6): e0218968. Woo Young Min, Kim Sehwa, Park Jong-Ho, Lee Nan Young, Kim Jong-Won, Kim Dennis Dong Hw |
|
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.
Blood 2018 Jul . Roberts Kathryn G, Reshmi Shalini C, Harvey Richard C, Chen I-Ming, Patel Kinnari, Stonerock Eileen, Jenkins Heather, Dai Yunfeng, Valentine Marc, Gu Zhaohui, Zhao Yaqi, Zhang Jinghui, Payne-Turner Debbie, Devidas Meenakshi, Heerema Nyla A, Carroll Andrew J, Raetz Elizabeth A, Borowitz Michael J, Wood Brent L, Mattano Leonard A, Maloney Kelly W, Carroll William L, Loh Mignon L, Willman Cheryl L, Gastier-Foster Julie M, Mullighan Charles G, Hunger Stephen |
|
Ikaros family zinc-finger 1 mutation is an independent factor for the poor prognosis of adult B-cell acute lymphoblastic leukemia, and allogeneic hematopoietic stem cell transplantation can improve clinical outcomes.
Bone marrow transplantation 2018 Jun . Tang Shanhao, Shen Hongjie, Qu Changju, Dai Haiping, Zhu Xiaming, Xue Shengli, Ding Zixuan, Lu Jing, Wu Depei, Tang Xiaow |
|
The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: results of a multicenter study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Jun . Stamatopoulos Basile, Smith Thomas, Crompot Emerence, Pieters Karlien, Clifford Ruth, Mraz Marek, Robbe Pauline, Burns Adam, Timbs Adele, Bruce David R, Hillmen Peter, Meuleman Nathalie, Mineur Philippe, Firescu Radu, Maerevoet Marie, De Wilde Virgine, Efira André A, Philippé Jan, Verhasselt Bruno, Offner Fritz, Sims David, Heger Andreas, Dreau Hélène, Schuh An |
|
[Relationship between High-Resolution HLA-A,-B,-DRB1 Alleles and Haplotype Polymorphisms with Myeloid Leukemia of Han People in North China].
Zhongguo shi yan xue ye xue za zhi 2018 Feb 26 (1): 32-41. Qi Jun, Wang Tian-Ju, Chen Li-Ping, Wang Man-Ni, Wu Jun-Hua, DU D |
|
Molecular screening and the clinical impacts of BCR-ABL KD mutations in patients with imatinib-resistant chronic myeloid leukemia.
Oncology letters 2018 Feb 15 (2): 2419-2424. Koçkan Betül, Topta? Tayfur, Atagündüz I?ik, Tu?lular Ay?e Tülin, Özer Ay?e, Akkiprik Musta |
|
The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia.
Human immunology 2017 Oct . Zhang Amin, Yu Jie, Yan Shuxin, Zhao Xia, Chen Chen, Zhou Ying, Zhao Xueyun, Hua Mingqiang, Wang Ruiqing, Zhang Chen, Zhong Chaoqin, He Na, Ji Chunyan, Ma Daox |
|
[Variation of LNK Gene in Chronic Myeloid Leukemia].
Zhongguo shi yan xue ye xue za zhi 2017 Jun 25 (3): 706-710. Tan Mei, Rong Ying, Tian Run-Mei, Zhu Yu-Hang, Zhu Ping, Chen Y |
|
Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.
Blood cancer journal 2017 Apr 7 (4): e559. Togasaki E, Takeda J, Yoshida K, Shiozawa Y, Takeuchi M, Oshima M, Saraya A, Iwama A, Yokote K, Sakaida E, Hirase C, Takeshita A, Imai K, Okumura H, Morishita Y, Usui N, Takahashi N, Fujisawa S, Shiraishi Y, Chiba K, Tanaka H, Kiyoi H, Ohnishi K, Ohtake S, Asou N, Kobayashi Y, Miyazaki Y, Miyano S, Ogawa S, Matsumura I, Nakaseko C, Naoe |
|
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment.
Journal of experimental & clinical cancer research : CR 2017 Apr 36 (1): 55. Jaruskova Monika, Curik Nikola, Hercog Rajna, Polivkova Vaclava, Motlova Eliska, Benes Vladimir, Klamova Hana, Pecherkova Pavla, Belohlavkova Petra, Vrbacky Filip, Machova Polakova Kateri |
|
[Clinical significance of cytogenetic monitoring in chronic myeloid leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017 Feb 38 (2): 112-117. Pan C Y, Xu N, He B L, Cao R, Liao L B, Yin C X, Lan Y Q, Lu Z Y, Huang J X, Sun J, Feng R, Liu Q F, Liu X |
|
Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
Haematologica 2017 Jan 102 (1): 130-138. Herold Tobias, Schneider Stephanie, Metzeler Klaus H, Neumann Martin, Hartmann Luise, Roberts Kathryn G, Konstandin Nikola P, Greif Philipp A, Bräundl Kathrin, Ksienzyk Bianka, Huk Natalia, Schneider Irene, Zellmeier Evelyn, Jurinovic Vindi, Mansmann Ulrich, Hiddemann Wolfgang, Mullighan Charles G, Bohlander Stefan K, Spiekermann Karsten, Hoelzer Dieter, Brüggemann Monika, Baldus Claudia D, Dreyling Martin, Gökbuget Nico |
|
Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
American journal of clinical pathology 2016 Oct 146 (4): 448-55. Gardner Juli-Anne, Peterson Jason D, Turner Scott A, Soares Barbara L, Lancor Courtney R, Dos Santos Luciana L, Kaur Prabhjot, Ornstein Deborah L, Tsongalis Gregory J, de Abreu Francine |
|
Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS).
Leukemia research 2016 Oct 49 108-12. Berman Ellin, Jhanwar Suresh, Hedvat Cyrus, Arcila Maria E, Wahab Omar Abdel-, Levine Ross, Maloy Molly, Ma Wanlong, Albitar Mah |
|
ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.
Asia-Pacific journal of clinical oncology 2016 Sep . Valikhani Amir, Poopak Behzad, Ferdowsi Shirin, Azizi Tabesh Ghasem, Ghaffari Seyed H, Saraf Kazeruoni Ehsan, Rezaei Negar, Farshchi Alireza, Amirizadeh Nas |
|
Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudy.
Leukemia research 2016 Sep 51 11-18. Miyamura Koichi, Miyamoto Toshihiro, Tanimoto Mitsune, Yamamoto Kazuhito, Kimura Shinya, Kawaguchi Tatsuya, Matsumura Itaru, Hata Tomoko, Tsurumi Hisashi, Saito Shigeki, Hino Masayuki, Tadokoro Seiji, Meguro Kuniaki, Hyodo Hideo, Yamamoto Masahide, Kubo Kohmei, Tsukada Junichi, Kondo Midori, Aoki Makoto, Okada Hikaru, Yanada Masamitsu, Ohyashiki Kazuma, Taniwaki Masafu |
|
Chronic lymphocytic leukemia immunoglobulins display broad bacterial reactivity that converges and diverges from auto-/poly-reactivity and IGHV mutation status.
Clinical immunology (Orlando, Fla.) 2016 Aug . Hatzi Katerina, Catera Rosa, Atanasio Carolina Moreno, Fischetti Vincent A, Allen Steven L, Kolitz Jonathan E, Rai Kanti R, Chu Charles C, Chiorazzi Nichol |
|
The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms.
Blood cells, molecules & diseases 2016 Jul 59 25-30. Berzoti-Coelho Maria Gabriela, Ferreira Aline Fernanda, de Souza Nunes Natalia, Pinto Mariana Tomazini, Júnior Maurício Cristiano Rocha, Simões Belinda Pinto, Martínez-A Carlos, Souto Elizabeth Xisto, Panepucci Rodrigo Alexandre, Covas Dimas Tadeu, Kashima Simone, Castro Fabíola Att |
|
TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome.
Blood cells, molecules & diseases 2016 Jul 59 129-33. Weich Natalia, Ferri Cristian, Moiraghi Beatriz, Bengió Raquel, Giere Isabel, Pavlovsky Carolina, Larripa Irene, Fundia Arie |
|
Characterization of leukemias with ETV6-ABL1 fusion.
Haematologica 2016 May . Zaliova Marketa, Moorman Anthony V, Cazzaniga Giovanni, Stanulla Martin, Harvey Richard C, Roberts Kathryn G, Heatley Sue L, Loh Mignon L, Konopleva Marina, Chen I-Ming, Zimmermannova Olga, Schwab Claire, Smith Owen, Mozziconacci Marie-Joelle, Chabannon Christian, Kim Myungshin, Falkenburg J H Frederik, Norton Alice, Marshall Karen, Haas Oskar A, Starkova Julia, Stuchly Jan, Hunger Stephen P, White Deborah, Mullighan Charles G, Willman Cheryl L, Stary Jan, Trka Jan, Zuna J |
|
Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients.
Blood cells, molecules & diseases 2016 Mar 57 54-7. Macedo Luciana Conci, de Cesare Quintero Fernanda, Pagliari-E-Silva Sara, Pagnano Katia Borgia Barbosa, Rodrigues Camila, de Alencar Josiane Bazzo, Sell Ana Maria, Visentainer Jeane Eliete Lagui |
|
Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistance.
Leukemia & lymphoma 2016 Mar 1-8. Patkar Nikhil, Ghodke Kiran, Joshi Swapnali, Chaudhary Shruti, Mascerhenas Russel, Dusseja Sona, Mahadik Shashikant, Gaware Sheetal, Tembhare Prashant, Gujral Sumeet, Kabre Sharayu, Kadam-Amare Pratibha, Jain Hasmukh, Dangi Uma, Bagal Bhausaheb, Khattry Navin, Sengar Manju, Arora Brijesh, Narula Gaurav, Banavali Shripad, Menon Hari, Subramanian Papagudi Ganes |
|
Whole Exome Sequencing of Chronic Myeloid Leukemia Patients.
Iranian journal of public health 2016 Mar 45 (3): 346-52. Sabri Shaghayegh, Keyhani Manouchehr, Akbari Mohammad Tag |
|
[Characteristics and clinical outcome of T315I mutation in Philadelphia chromosome-positive acute lymphoblastic leukemia and chronic myeloid leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2016 Feb 37 (2): 110-4. Wang Juan, Zhang Yanli, Zu Yingling, Li Zhen, Li Mengjuan, Song Yongpi |
|
Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALL.
Blood 2016 08 128 (6): 774-82. Rousselot Philippe, Coudé Marie Magdelaine, Gokbuget Nicola, Gambacorti Passerini Carlo, Hayette Sandrine, Cayuela Jean-Michel, Huguet Françoise, Leguay Thibaut, Chevallier Patrice, Salanoubat Celia, Bonmati Caroline, Alexis Magda, Hunault Mathilde, Glaisner Sylvie, Agape Philippe, Berthou Christian, Jourdan Eric, Fernandes José, Sutton Laurent, Banos Anne, Reman Oumedaly, Lioure Bruno, Thomas Xavier, Ifrah Norbert, Lafage-Pochitaloff Marina, Bornand Anne, Morisset Laure, Robin Valérie, Pfeifer Heike, Delannoy Andre, Ribera Josep, Bassan Renato, Delord Marc, Hoelzer Dieter, Dombret Herve, Ottmann Oliver G, |
|
GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response.
Cancer epidemiology 2016 10 44 16-21. Weich Natalia, Ferri Cristian, Moiraghi Beatriz, Bengió Raquel, Giere Isabel, Pavlovsky Carolina, Larripa Irene B, Fundia Ariela |
|
The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms.
PloS one 2016 11 (4): e0154183. Chen Yan, Fang Fang, Hu Yang, Liu Qian, Bu Dingfang, Tan Mei, Wu Liusong, Zhu Pi |
|
Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Nov . Edathara Prajitha Mohandas, Gorre Manjula, Kagita Sailaja, Vuree Sugunakar, Cingeetham Anuradha, Nanchari Santhoshi Rani, Meka Phanni Bhushann, Annamaneni Sandhya, Digumarthi Raghunadha Rao, Satti Vishnupri |
|
Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a synergism between cytoreductive therapy and the common TERT polymorphism rs2736100.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct . Krahling Tunde, Balassa Katalin, Kiss Katalin P, Bors Andras, Batai Arpad, Halm Gabriella, Egyed Miklos, Fekete Sandor, Remenyi Peter, Masszi Tamas, Tordai Attila, Andrikovics Hajnal |
|
Donor Killer Immunoglobulin-like Receptors Profile Bx1 Impart a Negative Effect whereas Centromeric B-specific Gene Motifs Render a Positive Effect on Standard Risk AML/MDS Patient Survival after Unrelated Donor Hematopoietic Stem Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2015 Sep . Bao Xiaojing, Wang Miao, Zhou Huifen, Zhang Huanhuan, Wu Xiaojin, Yuan Xiaoni, Li Yang, Wu Depei, He J |
|
BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival.
Cancer investigation 2015 Aug . Pagnano Katia Borgia Barbosa, Bendit Israel, Boquimpani Carla, De Souza Carmino Antonio, Miranda Eliana C M, Zalcberg Ilana, Larripa Irene, Nardinelli Luciana, Silveira Rosana Antunes, Fogliatto Laura, Spector Nelson, Funke Vaneuza, Pasquini Ricardo, Hungria Vania, Sérgio Chiattone Carlos, Clementino Nelma, Conchon Monika, Moiraghi Elena Beatriz, Lopez Jose Luis, Pavlovsky Carolina, Pavlovsky Miguel A, Cervera Eduardo E, Meillon Luis Antonio, Simões Belinda, Hamerschlak Nelson, Bozzano Alicia Helena Magarinos, Mayta Ernesto, Cortes Jorge, Bengió 5 On Behalf Of Latin American Leukemia Net Lalnet Raquel |
|
BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival.
Cancer investigation 2015 Aug 1-8. Pagnano Katia Borgia Barbosa, Bendit Israel, Boquimpani Carla, De Souza Carmino Antonio, Miranda Eliana C M, Zalcberg Ilana, Larripa Irene, Nardinelli Luciana, Silveira Rosana Antunes, Fogliatto Laura, Spector Nelson, Funke Vaneuza, Pasquini Ricardo, Hungria Vania, Chiattone Carlos Sérgio, Clementino Nelma, Conchon Monika, Moiraghi Elena Beatriz, Lopez Jose Luis, Pavlovsky Carolina, Pavlovsky Miguel A, Cervera Eduardo E, Meillon Luis Antonio, Simões Belinda, Hamerschlak Nelson, Bozzano Alicia Helena Magarinos, Mayta Ernesto, Cortes Jorge, Bengió Raquel M, |
|
Genetic variations of hOCT1 gene and CYP3A4/A5 genes and their association with imatinib response in Chronic Myeloid Leukemia.
European journal of pharmacology 2015 Aug 765 124-130. Vaidya Shantashri, Ghosh Kanjaksha, Shanmukhaiah Chandrakala, Vundinti Babu R |
|
Patients with Philadelphia-positive leukemia with Y253H or F359V mutation have a high risk of developing new mutations in the setting of dasatinib resistance.
Leukemia & lymphoma 2015 Jul 56 (7): 2075-81. Jiang Qian, Qin Ya-Zhen, Lai Yue-Yun, Jiang Hao, Wang Jing, Huang Xiao-J |
|
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia.
Leukemia & lymphoma 2015 May 1-9. Maura Francesco, Cutrona Giovanna, Mosca Laura, Matis Serena, Lionetti Marta, Fabris Sonia, Agnelli Luca, Colombo Monica, Massucco Carlotta, Ferracin Manuela, Zagatti Barbara, Reverberi Daniele, Gentile Massimo, Recchia Anna Grazia, Bossio Sabrina, Rossi Davide, Gaidano Gianluca, Molica Stefano, Cortelezzi Agostino, Di Raimondo Francesco, Negrini Massimo, Tassone Pierfrancesco, Morabito Fortunato, Ferrarini Manlio, Neri Antoni |
|
Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib.
Journal of human genetics 2015 Mar . Rostami Golale, Hamid Mohammad, Yaran Majid, Khani Mohsen, Karimipoor Morte |
|
Emergence of BCR-ABL kinase domain mutations associated with newly diagnosed chronic myeloid leukemia: a meta-analysis of clinical trials of tyrosine kinase inhibitors.
Journal of managed care & specialty pharmacy 2015 Feb 21 (2): 114-22. Ursan Iulia D, Jiang Ruixuan, Pickard Evan M, Lee Todd A, Ng Daniel, Pickard A Sim |
|
New Mutations of the ID1 Gene in Acute Myeloid Leukemia Patients.
Pathobiology : journal of immunopathology, molecular and cellular biology 2015 Feb 82 (1): 43-47. Tochareontanaphol Chintana, Sinthuwiwat Thivaratana, Buathong Borisuit, Thita Thunyatip, Promso Somying, Paca-Uccaralertkun Saowak |
A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults.
Blood 2015 Jan 125 (4): 680-6. Perez-Andreu Virginia, Roberts Kathryn G, Xu Heng, Smith Colton, Zhang Hui, Yang Wenjian, Harvey Richard C, Payne-Turner Debbie, Devidas Meenakshi, Cheng I-Ming, Carroll William L, Heerema Nyla A, Carroll Andrew J, Raetz Elizabeth A, Gastier-Foster Julie M, Marcucci Guido, Bloomfield Clara D, Mrózek Krzysztof, Kohlschmidt Jessica, Stock Wendy, Kornblau Steven M, Konopleva Marina, Paietta Elisabeth, Rowe Jacob M, Luger Selina M, Tallman Martin S, Dean Michael, Burchard Esteban G, Torgerson Dara G, Yue Feng, Wang Yanli, Pui Ching-Hon, Jeha Sima, Relling Mary V, Evans William E, Gerhard Daniela S, Loh Mignon L, Willman Cheryl L, Hunger Stephen P, Mullighan Charles G, Yang Jun |
|
Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.
Haematologica 2015 Jan 100 (1): 55-61. Safavi Setareh, Hansson Markus, Karlsson Karin, Biloglav Andrea, Johansson Bertil, Paulsson Kaj |
|
The effect of BIM deletion polymorphism on intrinsic resistance and clinical outcome of cancer patient with kinase inhibitor therapy.
Scientific reports 2015 5 11348. Ying Hou-Qun, Chen Jie, He Bang-Shun, Pan Yu-Qin, Wang Feng, Deng Qi-Wen, Sun Hui-Ling, Liu Xian, Wang Shu-K |
|
Incidence of Bcr-Abl kinase domain mutations in imatinib refractory chronic myeloid leukemia patients from South India.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jul 35 (7): 7187-93. Kagita Sailaja, Uppalapati Srihari, Jiwatani Sangeeta, Linga Vijay Gandhi, Gundeti Sadasivudu, Nagesh Narayana, Digumarti Raghunadhar |
|
ABCB1 haplotypes are associated with P-gp activity and affect a major molecular response in chronic myeloid leukemia patients treated with a standard dose of imatinib.
Oncology letters 2014 Apr 7 (4): 1313-1319. Vivona Douglas, Lima Luciene Terezina, Rodrigues Alice Cristina, Bueno Carolina Tosin, Alcantara Greyce Kelly Steinhorst, Barros Luiza Saldanha Ribeiro, DE Moraes Hungria Vania Tiestsche, Chiattone Carlos Sérgio, DE Lourdes Lopes Ferrari Chauffaille Maria, Guerra-Shinohara Elvira Mar |
|
Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia.
International journal of clinical oncology 2014 Apr 19 (2): 391-6. Shibata Takashi, Minami Yosuke, Mitsuma Ayako, Morita Sachi, Inada-Inoue Megumi, Oguri Tomoyo, Shimokata Tomoya, Sugishita Mihoko, Naoe Tomoki, Ando Yuic |
|
BCR-ABL kinase domain mutations, including 2 novel mutations in imatinib resistant Malaysian chronic myeloid leukemia patients-Frequency and clinical outcome.
Leukemia research 2014 Apr 38 (4): 454-9. Elias Marjanu Hikmah, Baba Abdul Aziz, Azlan Husin, Rosline Hassan, Sim Goh Ai, Padmini Menon, Fadilah S Abdul Wahid, Ankathil Ravindr |
|
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia.
Medical oncology (Northwood, London, England) 2014 Mar 31 (3): 851. de Lima Luciene Terezina, Vivona Douglas, Bueno Carolina Tosin, Hirata Rosario D C, Hirata Mario H, Luchessi André D, de Castro Fabíola Attié, de Lourdes F Chauffaille Maria, Zanichelli Maria A, Chiattone Carlos S, Hungria Vania T M, Guerra-Shinohara Elvira |
|
Frequency of JAK2 V617F mutation in patients with Philadelphia positive Chronic Myeloid Leukemia in Pakistan.
Pakistan journal of medical sciences 2014 Jan 30 (1): 185-8. Tabassum Najia, Saboor Mohammed, Ghani Rubina, Moinuddin Moinudd |
|
Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.
The Journal of molecular diagnostics : JMD 2014 Jan 16 (1): 56-67. Pritchard Colin C, Salipante Stephen J, Koehler Karen, Smith Christina, Scroggins Sheena, Wood Brent, Wu David, Lee Ming K, Dintzis Suzanne, Adey Andrew, Liu Yajuan, Eaton Keith D, Martins Renato, Stricker Kari, Margolin Kim A, Hoffman Noah, Churpek Jane E, Tait Jonathan F, King Mary-Claire, Walsh T |
|
Detection of ABL1 kinase mutations in Philadelphia-positive patients exhibiting an inadequate molecular response using restriction fragment mass polymorphism and its clinical significance: a single-center experience in Korea.
International journal of laboratory hematology 2013 Dec 35 (6): 589-600. Cho Y-U, Kim S-O, Chi H-S, Park S-J, Jang S, Park C-J, Seo E-J, Lee J-H, Lee J-H, Lee K-H, Im H-J, Seo J-J, Hong S |
|
The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis.
Haematologica 2013 Oct 98 (10): 1510-6. Nicolini Franck E, Ibrahim Amr R, Soverini Simona, Martinelli Giovanni, Müller Martin C, Hochhaus Andreas, Dufva Inge H, Kim Dong-Wook, Cortes Jorge, Mauro Michael J, Chuah Charles, Labussière Hélène, Morisset Stéphane, Roche-Lestienne Catherine, Lippert Eric, Hayette Sandrine, Peter Senaka, Zhou Wei, Maguer-Satta Véronique, Michallet Mauricette, Goldman John, Apperley Jane F, Mahon François-Xavier, Marin David, Etienne Gabri |
|
Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.
Blood 2013 Jun 121 (24): 4902-5. Rossi Davide, Spina Valeria, Bomben Riccardo, Rasi Silvia, Dal-Bo Michele, Bruscaggin Alessio, Rossi Francesca Maria, Monti Sara, Degan Massimo, Ciardullo Carmela, Serra Roberto, Zucchetto Antonella, Nomdedeu Josep, Bulian Pietro, Grossi Alberto, Zaja Francesco, Pozzato Gabriele, Laurenti Luca, Efremov Dimitar G, Di-Raimondo Francesco, Marasca Roberto, Forconi Francesco, Del Poeta Giovanni, Gaidano Gianluca, Gattei Valt |
|
The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer.
Molecular biology reports 2013 Jun 40 (6): 4109-14. Ouerhani Slah, Bougatef Karim, Soltani Ismail, Elgaaied Amel Ben Ammar, Abbes Salem, Menif Sam |
|
Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India.
Hematology (Amsterdam, Netherlands) 2013 May 18 (3): 163-8. Annamaneni Sandhya, Gorre Manjula, Kagita Sailaja, Addepalli Kasyap, Digumarti Raghunadha Rao, Satti Vishnupriya, Battini Mohan Red |
|
Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance.
Hematology (Amsterdam, Netherlands) 2013 May 18 (3): 158-62. Chahardouli Bahram, Zaker Farhad, Mousavi Seied Asadollah, Kazemi Ahmad, Ostadali Mohammadreza, Nadali Fatemeh, Rostami Shahrbano, Alimoghaddam Kamran, Ghavamzade Ardesh |
|
Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML.
The New England journal of medicine 2013 May 368 (19): 1781-90. Maxson Julia E, Gotlib Jason, Pollyea Daniel A, Fleischman Angela G, Agarwal Anupriya, Eide Christopher A, Bottomly Daniel, Wilmot Beth, McWeeney Shannon K, Tognon Cristina E, Pond J Blake, Collins Robert H, Goueli Basem, Oh Stephen T, Deininger Michael W, Chang Bill H, Loriaux Marc M, Druker Brian J, Tyner Jeffrey |
|
Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib.
Oncology reports 2013 Feb 29 (2): 741-50. Gromicho Marta, Magalhães Marta, Torres Fátima, Dinis Joana, Fernandes Alexandra R, Rendeiro Paula, Tavares Purificação, Laires António, Rueff José, Sebastião Rodrigues Antón |
|
BCR-ABL1 Kinase Domain Mutation Analysis in an Irish Cohort of Chronic Myeloid Leukemia Patients.
Genetic testing and molecular biomarkers 2013 Jan . McCarron SL, O'Connor LM, Langabeer SE, Conneally E |
|
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia.
Annals of hematology 2013 Jan 92 (2): 179-83. Tiribelli Mario, Latagliata Roberto, Luciano Luigiana, Castagnetti Fausto, Gozzini Antonella, Cambrin Giovanna Rege, Annunziata Mario, Stagno Fabio, Pregno Patrizia, Albano Francesco, Abruzzese Elisabetta, Musto Pellegrino, Montefusco Enrico, Fava Carmen, Fanin Renato, Pane Fabrizio, Rosti Gianantonio, Breccia Massimo, Alimena Giuliana, Vigneri Pao |
|
Sensitive detection of pre-existing BCR-ABL kinase domain mutations in CD34+ cells of newly diagnosed chronic-phase chronic myeloid leukemia patients is associated with imatinib resistance: implications in the post-imatinib era.
PloS one 2013 8 (2): e55717. Iqbal Zafar, Aleem Aamer, Iqbal Mudassar, Naqvi Mubashar Iqbal, Gill Ammara, Taj Abid Sohail, Qayyum Abdul, ur-Rehman Najeeb, Khalid Ahmad Mukhtar, Shah Ijaz Hussain, Khalid Muhammad, Haq Riazul, Khan Mahwish, Baig Shahid Mahmood, Jamil Abid, Abbas Muhammad Naeem, Absar Muhammad, Mahmood Amer, Rasool Mahmood, Akhtar Tanve |
|
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.
Experimental hematology 2012 Nov 40 (11): 906-913.e1. Kreutzman Anna, Jaatinen Taina, Greco Dario, Vakkila Emmi, Richter Johan, Ekblom Marja, Hjorth-Hansen Henrik, Stenke Leif, Melo Teresa, Paquette Ron, Seggewiss-Bernhardt Ruth, Guerci-Bresler Agnés, Talbot Alexis, Cayuela Jean Michel, Mahon Francois-Xavier, Porkka Kimmo, Lipton Jeff, Partanen Jukka, Rousselot Philippe, Mustjoki Sa |
|
Genetic polymorphisms of NQO1, CYP1A1 and TPMT and susceptibility to acute lymphoblastic leukemia in a Tunisian population.
Molecular biology reports 2012 Oct . Ouerhani S, Cherif N, Bahri I, Safra I, Menif S, Abbes S |
|
Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.
Haematologica 2012 Oct 97 (10): 1582-5. Schnittger Susanne, Bacher Ulrike, Eder Christiane, Dicker Frank, Alpermann Tamara, Grossmann Vera, Kohlmann Alexander, Kern Wolfgang, Haferlach Claudia, Haferlach Torst |
|
Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation.
Clinical epigenetics 2012 Aug 4 (1): 1. Bennemann K, Galm O, Wilop S, Schubert C, Bruemmendorf TH, Jost E |
|
BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naïve and -exposed Southeast Asian chronic myeloid leukemia patients.
Experimental and molecular pathology 2012 Jan . Wongboonma W, Thongnoppakhun W, Auewarakul CU |
|
Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis.
Journal of the Formosan Medical Association = Taiwan yi zhi 2012 Jan 111 (1): 34-40. Ho Ching-Liang, Wu Yi-Ying, Hung Hsiu-Man, Chang Ping-Ying, Kao Wei-You, Chen Yeu-Chin, Chao Tsu- |
|
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Dec 17 (23): 7413-23. Iacobucci Ilaria, Ferrari Anna, Lonetti Annalisa, Papayannidis Cristina, Paoloni Francesca, Trino Stefania, Storlazzi Clelia Tiziana, Ottaviani Emanuela, Cattina Federica, Impera Luciana, Abbenante Maria Chiara, Vignetti Marco, Vitale Antonella, Potenza Leonardo, Paolini Stefania, Soverini Simona, Pane Fabrizio, Luppi Mario, Foà Robin, Baccarani Michele, Martinelli Giovan |
|
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 2011 Sep 118 (11): 3080-7. Zhang Jinghui, Mullighan Charles G, Harvey Richard C, Wu Gang, Chen Xiang, Edmonson Michael, Buetow Kenneth H, Carroll William L, Chen I-Ming, Devidas Meenakshi, Gerhard Daniela S, Loh Mignon L, Reaman Gregory H, Relling Mary V, Camitta Bruce M, Bowman W Paul, Smith Malcolm A, Willman Cheryl L, Downing James R, Hunger Stephen |
|
JAK2V617F mutation in chronic myeloid leukemia predicts early disease progression.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2011 Aug 21 (8): 472-5. Pahore Zaen-Al-Abideen, Shamsi Tahir S, Taj Mehwesh, Farzana Tasneem, Ansari Saqib H, Nadeem Muhammad, Ahmad Masood, Naz Ars |
|
Pharmacokinetic impact of SLCO1A2 polymorphisms on imatinib disposition in patients with chronic myeloid leukemia.
Clinical pharmacology and therapeutics 2011 Jul 90 (1): 157-63. Yamakawa Y, Hamada A, Shuto T, Yuki M, Uchida T, Kai H, Kawaguchi T, Saito |
|
The role of the loss of CDKN2A gene on prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia (ALL).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): 6532. Iacobucci I, Ferrari A, Lonetti A, Papayannidis C, Paoloni F, Abbenante M, Guadagnuolo V, Ottaviani E, Cattina F, Vitale A, Paolini S, Soverini S, Parisi S, Vignetti M, Baccarani M, Martinelli |
|
Rapid and sensitive allele-specific (AS)-RT-PCR assay for detection of T315I mutation in chronic myeloid leukemia patients treated with tyrosine-kinase inhibitors.
Clinical and experimental medicine 2011 Mar 11 (1): 55-9. Manrique Arechavaleta Gonzalo, Scholl Vanesa, Pérez Verónica, Bittencourt Roberta, Moellmann Arthur, Hassan Rocio, Seuánez Héctor N, Dobbin Jane, Martinez Lem, Renault Ilana Zalcberg, Uriarte Rosar |
|
Mutations of perforin gene in Chinese patients with acute lymphoblastic leukemia.
Leukemia research 2011 Feb 35 (2): 196-9. Yang Liyun, Liu Hongxing, Zhao Jun, Da Wanming, Zheng Jingchen, Wang Lixiang, Li Gong, Zhu Pi |
|
Characteristics of BCR-ABL kinase domain point mutations in Chinese imatinib-resistant chronic myeloid leukemia patients.
Annals of hematology 2011 Jan 90 (1): 47-52. Qin Yazhen, Chen Shanshan, Jiang Bin, Jiang Qian, Jiang Hao, Li Jinlan, Li Lingdi, Lai Yueyun, Liu Yanrong, Huang Xiaoj |
|
Use of direct sequencing for detection of mutations in the BCR-ABL kinase domain in Slovak patients with chronic myeloid leukemia.
Neoplasma 2011 58 (6): 548-53. Strhakova L, Bujalkova M Gerykov, Hojsikova I, Lukackova R, Behulova R, Mistrik M, Repiska |
|
Human leukocyte antigen class I alleles and the risk of chronic myelogenous leukemia: a meta-analysis.
Leukemia & lymphoma 2010 Jul 51 (7): 1288-92. Naugler Christopher, Liwski Robe |
|
XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia.
American journal of hematology 2010 Jul 85 (7): 482-6. Guillem Vicent M, Cervantes Francisco, Martínez Jesús, Alvarez-Larrán Alberto, Collado María, Camós Mireia, Sureda Anna, Maffioli Margherita, Marugán Isabel, Hernández-Boluda Juan-Carl |
|
[Detection of ABL kinase domain point mutations in chronic myeloid leukemia patients receiving imatinib treatment].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2010 Feb 18 (1): 49-53. Wu Lin-Lin, Zeng Qing-Shu, Yang Ming-Zhen, Miao Hua-Wei, Xia Rui-Xiang, Wang Lin, Ni Ji |
|
Chronic myeloid leukemia and BCR/ABL signal pathways are not associated with AKT1 pleckstrin homology domain (E17K) mutations.
European journal of haematology 2010 Jan 84 (1): 87-8. He Yanli, Zheng Jine, Hu Yanjie, Xiao Hong, Liu Jun, Li Xiaoqing, Du Wen, Chen Xiangjun, Hu Yu, Huang Shia |
|
Frequency of BCR-ABL gene mutations in Polish patients with chronic myeloid leukemia treated with imatinib: a final report of the MAPTEST study.
Polskie Archiwum Medycyny Wewn?trznej 2009 Dec 119 (12): 789-94. Lewandowski Krzysztof, Warzocha Krzysztof, Hellmann Andrzej, Skotnicki Aleksander, Prejzner Witold, Foryciarz Kajetana, Sacha Tomasz, Gniot Micha?, Majewski Miros?aw, Solarska Iwona, Nowak Grazyna, Wasag Bartosz, Kobelski Miko?aj, Scibiorski Cezary, Siemiatkowski Marek, Lewandowska Maria, Komarnicki Mieczys? |
|
IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Nov 27 (31): 5202-7. Martinelli Giovanni, Iacobucci Ilaria, Storlazzi Clelia Tiziana, Vignetti Marco, Paoloni Francesca, Cilloni Daniela, Soverini Simona, Vitale Antonella, Chiaretti Sabina, Cimino Giuseppe, Papayannidis Cristina, Paolini Stefania, Elia Loredana, Fazi Paola, Meloni Giovanna, Amadori Sergio, Saglio Giuseppe, Pane Fabrizio, Baccarani Michele, Foà Rob |
|
Clinical relevance of a pharmacogenetic approach using multiple candidate genes to predict response and resistance to imatinib therapy in chronic myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Jul 15 (14): 14. Kim DH, Sriharsha L, Xu W, Kamel-Reid S, Liu X, Siminovitch K, Messner HA, Lipton JH |
|
New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.
Leukemia & lymphoma 2009 Jul 50 (7): 1148-54. Mascarenhas Cintia C, Cunha Anderson F, Miranda Eliana C, Zulli Roberto, Silveira Rosana A, Costa Fernando F, Pagnano Katia B B, De Souza Carmino |
|
PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009 Jul . Familiades J, Bousquet M, Lafage-Pochitaloff M, Béné MC, Beldjord K, De Vos J, Dastugue N, Coyaud E, Struski S, Quelen C, Prade-Houdellier N, Dobbelstein S, Cayuela JM, Soulier J, Grardel N, Preudhomme C, Cavé H, Blanchet O, Lhéritier V, Delannoy A, Chalandon Y, Ifrah N, Pigneux A, Brousset P, Macintyre EA, Huguet F, Dombret H, Broccardo C, Delabesse E |
|
[Tyrosine kinase JAK2V617F mutation in human myeloproliferative disorders].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2009 Jun 17 (3): 541-4. Xu Yuan-Yuan, Li Hui-Min, Li Xiao-Jin, Yang Ling, Hu Deng-Mi |
|
GATA-2 L359 V mutation is exclusively associated with CML progression but not other hematological malignancies and GATA-2 P250A is a novel single nucleotide polymorphism.
Leukemia research 2009 Mar . Zhang SJ, Shi JY, Li JY |
|
Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia.
Blood 2009 Mar 113 (11): 2517-25. Kim Dong Hwan Dennis, Xu Wei, Ma Clement, Liu Xiangdong, Siminovitch Katherine, Messner Hans A, Lipton Jeffrey |
|
HLA risk markers for chronic myelogenous leukemia in Eastern Canada.
Leukemia & lymphoma 2009 Feb 50 (2): 254-9. Naugler Christopher, Liwski Robe |
|
ABL single nucleotide polymorphisms may masquerade as BCR-ABL mutations associated with resistance to tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Haematologica 2008 Sep 93 (9): 1389-93. Ernst Thomas, Hoffmann Jana, Erben Philipp, Hanfstein Benjamin, Leitner Armin, Hehlmann Rüdiger, Hochhaus Andreas, Müller Martin |
|
[Polymorphisms in the breakpoint cluster region of bcr gene.]
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2008 Jun 16 (3): 659-62. Tian H, Zhou SY |
|
MPL W515L mutation in Chinese patients with myeloproliferative diseases.
Leukemia & lymphoma 2008 May 49 (5): 955-8. Xu Wei, Li Jian-Yong, Xia Jun, Zhang Su-Jiang, Fan Lei, Qiao Ch |
|
UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia.
Leukemia 2007 Nov 21 (11): 2311-5. Singer J B, Shou Y, Giles F, Kantarjian H M, Hsu Y, Robeva A S, Rae P, Weitzman A, Meyer J M, Dugan M, Ottmann O |
|
Association of HLA class II allele and haplotype frequencies with chronic myelogenous leukemia and age-at-onset of the disease.
Pathology oncology research : POR 2007 13 (1): 47-51. Amirzargar Ali-Akbar, Khosravi Farideh, Dianat Saied S, Alimoghadam Kamran, Ghavamzadeh Fereidoun, Ansaripour Bita, Moradi Batool, Nikbin Behro |
- Page last reviewed:Mar 16, 2019
- Page last updated:Jun 01, 2020
- Content source: